Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical ...
Manufactured by
China
Founded in 1996, Shandong Kanghua Biotechnology specializes in IVD reagents and diagnostic analyzers, offering integrated medical diagnostic solutions. The company operates eight detection platforms including POCT, biochemistry, chemiluminescence, ELISA, coagulation, urinalysis, mass spectrometry, and molecular diagnostics, with over 500 registered products exported to 180+ countries. Certified by NMPA, ISO 13485, and CE, with nearly 50,000 sqm GMP production facilities.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 6 relevant products
Coei Biotech
China · 1 relevant product
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 1 relevant product
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
Anhui Deepblue Medical Technology Co., Ltd.
China · 3 relevant products
Shenzhen Tiachen Medical Technology CO., Ltd
China · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 3 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 3 relevant products
Hangzhou Fanttest Biotech Co., Ltd.
China · 2 relevant products
Hangzhou Biotest Biotech Co., Ltd
China · 2 relevant products
62 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 116 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic test kit for simultaneously detecting cardiac troponin I, myoglobin, and creatine kinase-MB using microfluidic immunofluorescence method. This kit is used for clinical laboratory testing to measure multiple cardiac markers in patient samples.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A microfluidic immunofluorescence-based detection kit for measuring cardiac troponin I levels in clinical samples. This kit is designed for cardiac injury detection and myocardial infarction diagnosis.
Coei Biotech · China
Immunofluorescence-based diagnostic test kit for detection and measurement of cardiac biomarkers in patient serum or plasma samples. Suitable for cardiac disease screening and monitoring.
Guangzhou Labsim Medical Diagnostics Co., Ltd. · China
Immunofluorescence reagents for detection of cardiac biomarkers including troponin and myoglobin. Applied in acute coronary syndrome and myocardial infarction diagnostics.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic reagent kit for detecting cardiac troponin I, myoglobin, and creatine kinase-MB using microfluidic immunofluorescence method. This multiplex test is used for acute myocardial infarction diagnosis.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.
Anhui Deepblue Medical Technology Co., Ltd. · China
Multiplex rapid test for simultaneous detection of cardiac troponin I, myoglobin, and CK-MB. Comprehensive cardiac marker panel for acute coronary syndrome evaluation.
Shenzhen Tiachen Medical Technology CO., Ltd · China
Cardiac biomarker immunoassay panel measuring troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (Myo) for rapid assessment of acute myocardial infarction and cardiac injury. Used with automated chemiluminescence analyzers for point-of-care and laboratory diagnostics.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.
Lumigenex (Suzhou) Co., Ltd · China
A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.
Hangzhou Fanttest Biotech Co., Ltd. · China
A multiplex rapid test for simultaneously detecting cardiac troponin I, myoglobin, and creatine kinase-MB. Provides comprehensive cardiac marker assessment for heart damage and stress evaluation.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products